Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

Why choose ATTO dyes for quantitative and digital PCR probes?

Previous post

Kaneka Eurogentec receives GMP accreditation for its new state-of-the-art facility in time for the production of DNA vaccines against COVID-19

Next post

Recommended for you

Why choose ATTO dyes for quantitative and d..

Products & Services

Choosing the right fluorescent dye is crucial for qPCR and dPCR applications. ATTO dyes, developed...
Continue Reading
22-25 September 2025

IBMS Congress

Birmingham, UK

Meet our experts at "IBMS Congress"

@ Birmingham, UK
Come meet our dedicated team at booth #F28, in Birmingham (UK), September 22-25, 2025....
Continue Reading
6-7 May 2025

TIDES of Innovation

Amsterdam, NL

Meet us at "TIDES of Innovation"

@ Amsterdam, NL
Meet our team at "The Pep and Oligo Summit", in Amsterdam (NL), May 6-7, 2025.
...
Continue Reading